
Global Internal Beam Radiotherapy Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Internal Beam Radiotherapy market size will reach US$ million by 2031.
Internal radiation therapy — also called brachytherapy or seed implantation — is a type of cancer treatment. It delivers a high dose of radiation directly to the tumor and helps spare nearby tissues.
With internal radiation therapy, the oncologist implants or inserts radioactive materials at the site of your cancer. The placement can be temporary or permanent.
United States market for Internal Beam Radiotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Internal Beam Radiotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Internal Beam Radiotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Internal Beam Radiotherapy players cover Varian Medical, Elekta, Accuray, Ion Beam, Hitachi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Internal Beam Radiotherapy Industry Forecast” looks at past sales and reviews total world Internal Beam Radiotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Internal Beam Radiotherapy sales for 2025 through 2031. With Internal Beam Radiotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Internal Beam Radiotherapy industry.
This Insight Report provides a comprehensive analysis of the global Internal Beam Radiotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Internal Beam Radiotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Internal Beam Radiotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Internal Beam Radiotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Internal Beam Radiotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Internal Beam Radiotherapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Low-dose-rate (LDR) Brachytherapy
High-dose-rate (HDR) Brachytherapy
Pulsed-dose-rate (PDR) Brachytherapy
Segmentation by Application:
Hospitals
Independent Radiotherapy Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Varian Medical
Elekta
Accuray
Ion Beam
Hitachi
Please note: The report will take approximately 2 business days to prepare and deliver.
Internal radiation therapy — also called brachytherapy or seed implantation — is a type of cancer treatment. It delivers a high dose of radiation directly to the tumor and helps spare nearby tissues.
With internal radiation therapy, the oncologist implants or inserts radioactive materials at the site of your cancer. The placement can be temporary or permanent.
United States market for Internal Beam Radiotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Internal Beam Radiotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Internal Beam Radiotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Internal Beam Radiotherapy players cover Varian Medical, Elekta, Accuray, Ion Beam, Hitachi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Internal Beam Radiotherapy Industry Forecast” looks at past sales and reviews total world Internal Beam Radiotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Internal Beam Radiotherapy sales for 2025 through 2031. With Internal Beam Radiotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Internal Beam Radiotherapy industry.
This Insight Report provides a comprehensive analysis of the global Internal Beam Radiotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Internal Beam Radiotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Internal Beam Radiotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Internal Beam Radiotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Internal Beam Radiotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Internal Beam Radiotherapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Low-dose-rate (LDR) Brachytherapy
High-dose-rate (HDR) Brachytherapy
Pulsed-dose-rate (PDR) Brachytherapy
Segmentation by Application:
Hospitals
Independent Radiotherapy Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Varian Medical
Elekta
Accuray
Ion Beam
Hitachi
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
80 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.